Hyperpolarized Xe129
Sponsors
Mario Castro, MD, MPH, University of Kansas Medical Center, Bastiaan Driehuys, Children's Hospital Medical Center, Cincinnati, University of Virginia
Conditions
Acute Pulmonary EmbolismAnemiaAsthmaCOPDChronic Thromboembolic Pulmonary HypertensionCovid19Cystic FibrosisDyspnea
Early Phase 1
Phase 1
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RecruitingNCT04624490
Start: 2020-11-02End: 2028-10-26Target: 260Updated: 2026-05-06
Hyperpolarized 129Xe MRI of Survivors of COVID-19
CompletedNCT04659707
Start: 2021-02-22End: 2025-05-01Updated: 2026-05-01
Phase 2
129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study
WithdrawnNCT04677426
Start: 2022-05-01End: 2022-08-01Updated: 2022-09-10
129Xe MRI Cardiopulmonary
RecruitingNCT06038630
Start: 2024-01-12End: 2028-06-30Target: 125Updated: 2026-02-04
Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)
WithdrawnNCT06122922
Start: 2024-03-15End: 2025-12-31Updated: 2024-01-23
Unknown Phase
MRI for Screening and Monitoring Scleroderma ILD
CompletedNCT05204355
Start: 2022-05-01End: 2025-10-31Updated: 2026-05-01
Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension
CompletedNCT05339386
Start: 2022-08-29End: 2025-07-31Updated: 2026-05-01
Hyperpolarized 129Xe MRI Lung Health Cohort
RecruitingNCT05766384
Start: 2023-11-30End: 2027-03-31Target: 260Updated: 2026-05-01